Oil & Gas Integrated
Compare Stocks
5 / 10Stock Comparison
CVE vs SU vs CVX vs XOM vs COP
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Integrated
Oil & Gas Integrated
Oil & Gas Exploration & Production
CVE vs SU vs CVX vs XOM vs COP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Integrated | Oil & Gas Exploration & Production |
| Market Cap | $53.60B | $75.67B | $364.18B | $620.85B | $140.02B |
| Revenue (TTM) | $49.40B | $52.01B | $184.43B | $323.90B | $58.31B |
| Net Income (TTM) | $4.64B | $6.33B | $12.30B | $28.84B | $7.32B |
| Gross Margin | 19.6% | 55.5% | 30.4% | 21.7% | 29.2% |
| Operating Margin | 14.0% | 27.4% | 9.0% | 10.5% | 18.3% |
| Forward P/E | 7.5x | 7.7x | 15.0x | 14.8x | 13.3x |
| Total Debt | $17.00B | $18.37B | $46.74B | $43.54B | $23.44B |
| Cash & Equiv. | $2.74B | $3.65B | $6.47B | $10.68B | $6.50B |
CVE vs SU vs CVX vs XOM vs COP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cenovus Energy Inc. (CVE) | 100 | 657.3 | +557.3% |
| Suncor Energy Inc. (SU) | 100 | 372.4 | +272.4% |
| Chevron Corporation (CVX) | 100 | 199.0 | +99.0% |
| Exxon Mobil Corpora… (XOM) | 100 | 322.2 | +222.2% |
| ConocoPhillips (COP) | 100 | 272.4 | +172.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CVE vs SU vs CVX vs XOM vs COP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CVE carries the broadest edge in this set and is the clearest fit for value and momentum.
- Lower P/E (7.5x vs 14.8x)
- +147.0% vs COP's +34.7%
- 7.8% ROA vs CVX's 4.2%, ROIC 7.9% vs 6.2%
SU is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth -3.5%, EPS growth 2.8%, 3Y rev CAGR -5.7%
- 197.4% 10Y total return vs COP's 233.4%
CVX ranks third and is worth considering specifically for dividends.
- 3.8% yield, 8-year raise streak, vs XOM's 2.7%
Among these 5 stocks, XOM doesn't own a clear edge in any measured category.
COP is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 0.08, yield 2.8%
- Lower volatility, beta 0.08, Low D/E 36.4%, current ratio 1.30x
- Beta 0.08, yield 2.8%, current ratio 1.30x
- 7.5% revenue growth vs CVE's -14.0%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.5% revenue growth vs CVE's -14.0% | |
| Value | Lower P/E (7.5x vs 14.8x) | |
| Quality / Margins | 12.6% margin vs CVX's 6.7% | |
| Stability / Safety | Beta 0.08 vs CVE's 0.22, lower leverage | |
| Dividends | 3.8% yield, 8-year raise streak, vs XOM's 2.7% | |
| Momentum (1Y) | +147.0% vs COP's +34.7% | |
| Efficiency (ROA) | 7.8% ROA vs CVX's 4.2%, ROIC 7.9% vs 6.2% |
CVE vs SU vs CVX vs XOM vs COP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CVE vs SU vs CVX vs XOM vs COP — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CVE leads in 2 of 6 categories
SU leads 1 • CVX leads 0 • XOM leads 0 • COP leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SU leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 6.6x CVE's $49.4B. COP is the more profitable business, keeping 12.6% of every revenue dollar as net income compared to CVX's 6.7%. On growth, SU holds the edge at +25.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $49.4B | $52.0B | $184.4B | $323.9B | $58.3B |
| EBITDAEarnings before interest/tax | $12.4B | $21.7B | $37.1B | $59.9B | $22.4B |
| Net IncomeAfter-tax profit | $4.6B | $6.3B | $12.3B | $28.8B | $7.3B |
| Free Cash FlowCash after capex | $4.4B | $7.2B | $16.2B | $23.6B | $18.3B |
| Gross MarginGross profit ÷ Revenue | +19.6% | +55.5% | +30.4% | +21.7% | +29.2% |
| Operating MarginEBIT ÷ Revenue | +14.0% | +27.4% | +9.0% | +10.5% | +18.3% |
| Net MarginNet income ÷ Revenue | +9.4% | +12.2% | +6.7% | +8.9% | +12.6% |
| FCF MarginFCF ÷ Revenue | +8.8% | +13.9% | +8.8% | +7.3% | +31.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -12.8% | +25.1% | -5.3% | -1.3% | -2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +78.7% | +30.1% | -24.5% | -11.0% | -20.2% |
Valuation Metrics
Evenly matched — CVE and SU each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 17.9x trailing earnings, SU trades at a 35% valuation discount to CVX's 27.5x P/E. On an enterprise value basis, SU's 5.1x EV/EBITDA is more attractive than XOM's 10.9x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $53.6B | $75.7B | $364.2B | $620.8B | $140.0B |
| Enterprise ValueMkt cap + debt − cash | $64.1B | $86.5B | $404.5B | $653.7B | $157.0B |
| Trailing P/EPrice ÷ TTM EPS | 18.06x | 17.93x | 27.53x | 21.86x | 18.09x |
| Forward P/EPrice ÷ next-FY EPS est. | 7.47x | 7.73x | 15.02x | 14.79x | 13.29x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 8.91x | 5.13x | 10.89x | 10.91x | 6.77x |
| Price / SalesMarket cap ÷ Revenue | 1.47x | 2.11x | 1.97x | 1.92x | 2.38x |
| Price / BookPrice ÷ Book value/share | 2.24x | 2.35x | 1.76x | 2.37x | 2.23x |
| Price / FCFMarket cap ÷ FCF | 21.48x | 14.92x | 21.95x | 26.29x | 8.35x |
Profitability & Efficiency
CVE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
CVE delivers a 15.2% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $7 for CVX. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to CVE's 0.54x. On the Piotroski fundamental quality scale (0–9), CVE scores 6/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.2% | +14.0% | +7.2% | +10.7% | +11.3% |
| ROA (TTM)Return on assets | +7.8% | +7.0% | +4.2% | +6.4% | +6.0% |
| ROICReturn on invested capital | +7.9% | +20.1% | +6.2% | +8.6% | +10.4% |
| ROCEReturn on capital employed | +8.2% | +19.5% | +6.6% | +8.9% | +10.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 6 | 5 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.54x | 0.41x | 0.24x | 0.16x | 0.36x |
| Net DebtTotal debt minus cash | $14.3B | $14.7B | $40.3B | $32.9B | $16.9B |
| Cash & Equiv.Liquid assets | $2.7B | $3.6B | $6.5B | $10.7B | $6.5B |
| Total DebtShort + long-term debt | $17.0B | $18.4B | $46.7B | $43.5B | $23.4B |
| Interest CoverageEBIT ÷ Interest expense | 11.80x | 11.68x | 17.22x | 69.44x | 9.42x |
Total Returns (Dividends Reinvested)
CVE leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CVE five years ago would be worth $38,679 today (with dividends reinvested), compared to $19,396 for CVX. Over the past 12 months, CVE leads with a +147.0% total return vs COP's +34.7%. The 3-year compound annual growth rate (CAGR) favors SU at 31.8% vs COP's 7.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +63.2% | +40.8% | +18.2% | +20.3% | +19.7% |
| 1-Year ReturnPast 12 months | +147.0% | +92.7% | +39.5% | +43.9% | +34.7% |
| 3-Year ReturnCumulative with dividends | +85.3% | +128.8% | +26.7% | +44.9% | +23.7% |
| 5-Year ReturnCumulative with dividends | +286.8% | +201.0% | +94.0% | +164.6% | +131.9% |
| 10-Year ReturnCumulative with dividends | +118.2% | +197.4% | +135.8% | +105.0% | +233.4% |
| CAGR (3Y)Annualised 3-year return | +22.8% | +31.8% | +8.2% | +13.2% | +7.3% |
Risk & Volatility
Evenly matched — CVE and XOM each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.15 beta — it tends to amplify market swings less than CVE's 0.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVE currently trades 92.3% from its 52-week high vs XOM's 83.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.22x | -0.03x | -0.05x | -0.15x | 0.08x |
| 52-Week HighHighest price in past year | $30.84 | $70.29 | $214.71 | $176.41 | $135.87 |
| 52-Week LowLowest price in past year | $11.60 | $33.50 | $133.77 | $101.19 | $84.28 |
| % of 52W HighCurrent price vs 52-week peak | +92.3% | +90.7% | +85.0% | +83.0% | +84.6% |
| RSI (14)Momentum oscillator 0–100 | 63.0 | 48.7 | 42.1 | 42.4 | 43.4 |
| Avg Volume (50D)Average daily shares traded | 13.1M | 4.6M | 11.0M | 18.9M | 9.6M |
Analyst Outlook
Evenly matched — CVX and XOM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CVE as "Hold", SU as "Buy", CVX as "Buy", XOM as "Hold", COP as "Buy". Consensus price targets imply 10.6% upside for COP (target: $127) vs -2.8% for CVE (target: $28). For income investors, CVX offers the higher dividend yield at 3.76% vs CVE's 2.01%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $27.67 | $62.00 | $190.93 | $160.43 | $127.07 |
| # AnalystsCovering analysts | 27 | 31 | 53 | 55 | 52 |
| Dividend YieldAnnual dividend ÷ price | +2.0% | +2.6% | +3.8% | +2.7% | +2.8% |
| Dividend StreakConsecutive years of raises | 0 | 4 | 8 | 26 | 1 |
| Dividend / ShareAnnual DPS | $0.78 | $2.30 | $6.87 | $4.00 | $3.19 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.4% | +3.0% | +3.3% | +3.3% | +3.6% |
CVE leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). SU leads in 1 (Income & Cash Flow). 3 tied.
CVE vs SU vs CVX vs XOM vs COP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CVE or SU or CVX or XOM or COP a better buy right now?
For growth investors, ConocoPhillips (COP) is the stronger pick with 7.
5% revenue growth year-over-year, versus -14. 0% for Cenovus Energy Inc. (CVE). Suncor Energy Inc. (SU) offers the better valuation at 17. 9x trailing P/E (7. 7x forward), making it the more compelling value choice. Analysts rate Suncor Energy Inc. (SU) a "Buy" — based on 31 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CVE or SU or CVX or XOM or COP?
On trailing P/E, Suncor Energy Inc.
(SU) is the cheapest at 17. 9x versus Chevron Corporation at 27. 5x. On forward P/E, Cenovus Energy Inc. is actually cheaper at 7. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CVE or SU or CVX or XOM or COP?
Over the past 5 years, Cenovus Energy Inc.
(CVE) delivered a total return of +286. 8%, compared to +94. 0% for Chevron Corporation (CVX). Over 10 years, the gap is even starker: COP returned +233. 4% versus XOM's +105. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CVE or SU or CVX or XOM or COP?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
15β versus Cenovus Energy Inc. 's 0. 22β — meaning CVE is approximately -254% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 54% for Cenovus Energy Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CVE or SU or CVX or XOM or COP?
By revenue growth (latest reported year), ConocoPhillips (COP) is pulling ahead at 7.
5% versus -14. 0% for Cenovus Energy Inc. (CVE). On earnings-per-share growth, the picture is similar: Cenovus Energy Inc. grew EPS 28. 7% year-over-year, compared to -31. 8% for Chevron Corporation. Over a 3-year CAGR, SU leads at -5. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CVE or SU or CVX or XOM or COP?
ConocoPhillips (COP) is the more profitable company, earning 13.
6% net margin versus 6. 7% for Chevron Corporation — meaning it keeps 13. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SU leads at 31. 7% versus 8. 8% for CVE. At the gross margin level — before operating expenses — SU leads at 59. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CVE or SU or CVX or XOM or COP more undervalued right now?
On forward earnings alone, Cenovus Energy Inc.
(CVE) trades at 7. 5x forward P/E versus 15. 0x for Chevron Corporation — 7. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for COP: 10. 6% to $127. 07.
08Which pays a better dividend — CVE or SU or CVX or XOM or COP?
All stocks in this comparison pay dividends.
Chevron Corporation (CVX) offers the highest yield at 3. 8%, versus 2. 0% for Cenovus Energy Inc. (CVE).
09Is CVE or SU or CVX or XOM or COP better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
15), 2. 7% yield, +105. 0% 10Y return). Both have compounded well over 10 years (XOM: +105. 0%, CVE: +118. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CVE and SU and CVX and XOM and COP?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CVE is a mid-cap quality compounder stock; SU is a mid-cap deep-value stock; CVX is a large-cap income-oriented stock; XOM is a large-cap quality compounder stock; COP is a mid-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.